135 related articles for article (PubMed ID: 9768606)
21. Screening mammography: value in women 35-39 years old.
Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
[TBL] [Abstract][Full Text] [Related]
22. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
23. Bilateral breast cancer: early detection with mammography.
Roubidoux MA; Helvie MA; Lai NE; Paramagul C
Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of in situ and invasive breast cancer in women aged under 45.
Weiss HA; Brinton LA; Brogan D; Coates RJ; Gammon MD; Malone KE; Schoenberg JB; Swanson CA
Br J Cancer; 1996 May; 73(10):1298-305. PubMed ID: 8630296
[TBL] [Abstract][Full Text] [Related]
25. Critical pathways in analyzing breast calcifications.
Bird RE
Radiographics; 1995 Jul; 15(4):928-34. PubMed ID: 7569137
[TBL] [Abstract][Full Text] [Related]
26. Screening mammography in women 40-49 years old.
Cardenosa G; Eklund GW
AJR Am J Roentgenol; 1995 May; 164(5):1104-6. PubMed ID: 7717213
[No Abstract] [Full Text] [Related]
27. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
[TBL] [Abstract][Full Text] [Related]
28. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
29. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
[TBL] [Abstract][Full Text] [Related]
30. Method of tumor detection influences disease-free survival of women with breast carcinoma.
Senie RT; Lesser M; Kinne DW; Rosen PP
Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
[TBL] [Abstract][Full Text] [Related]
31. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
32. Comparison of clinical and pathological characteristics between screen-detected and self-detected breast cancers: a Hong Kong study.
Lau SS; Cheung PS; Wong TT; Ma MK; Kwan WH
Hong Kong Med J; 2016 Jun; 22(3):202-9. PubMed ID: 27022189
[TBL] [Abstract][Full Text] [Related]
33. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
34. Trends in breast cancer at a county hospital.
Hoehne FM; Taylor E
Am Surg; 2005 Feb; 71(2):159-63. PubMed ID: 16022017
[TBL] [Abstract][Full Text] [Related]
35. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.
Lehman CD; Gatsonis C; Kuhl CK; Hendrick RE; Pisano ED; Hanna L; Peacock S; Smazal SF; Maki DD; Julian TB; DePeri ER; Bluemke DA; Schnall MD;
N Engl J Med; 2007 Mar; 356(13):1295-303. PubMed ID: 17392300
[TBL] [Abstract][Full Text] [Related]
36. Current management of ductal carcinoma in situ.
Barth A; Brenner RJ; Giuliano AE
West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer screening.
Warner EA
Prim Care; 1992 Sep; 19(3):575-88. PubMed ID: 1410064
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
39. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations.
Kolb TM; Lichy J; Newhouse JH
Radiology; 2002 Oct; 225(1):165-75. PubMed ID: 12355001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
